Sign up
Quantellect · Congress · Politician Profile
Q Score Rank#59 of 77

Carol D. Miller Stock Trades

U.S. Representative · Republican-WV
UnknownHealthcareConsumer Defensive

Congressional Stock Trades & Disclosures

Carol D. Miller is a U.S. Representative, a Republican representing WV. As of August 2026, Quantellect has tracked 123 disclosed stock trades across 78 companies, representing $3M in disclosed transaction value, each filed publicly under the STOCK Act.

About Carol D. Miller's congressional trading

Carol D. Miller Congressional Trading Profile | Quantellect Carol D. Miller Congressional Trading Profile

Carol D. Miller's most recent disclosure, filed on August 13, 2026, reports four sales with a transaction date of March 10, 2025, and every one is attributed to her spouse. Each of those securities also appears as a self-attributed sale in a separate, earlier-filed report covering the same transaction date. Across the broader record, both spouse- and self-attributed activity repeatedly returns to some of the same widely traded names.

Across the full disclosure history, which stretches from December 2018 through March 2025, 123 transactions have been filed under Miller's name. Of those, 71 are attributed to her spouse and 52 are self-attributed, with no joint or dependent-child transactions recorded. That split matters. A reader trying to understand Carol Miller's trading disclosures is looking at two distinct attribution streams: spouse-attributed activity that appears in concentrated bursts and self-attributed activity spread across index funds, bond ETFs, and individual equities.

A trading pattern built on repetition

The most frequently disclosed securities are a study in repetition. Quest Diagnostics (DGX), Pfizer (PFE), and Target (TGT) each appear four times, split evenly between two purchases and two sales. British American Tobacco (BTI), Clorox (CLX), and Dominion Energy (D) each show three transactions. U.S. Bancorp (USB) also appears three times, with one purchase and two sales. The transaction history repeatedly returns to some of the same securities while also encompassing many names that appear only once or twice.

Year to year, the volume of activity has swung considerably. 2020 was the busiest year on record with 31 transactions, followed by 23 in 2021 and 22 in 2022. Activity then cooled to 9 transactions in 2023 before ticking back up to 11 in 2024, all of which were sales, and 18 in 2025, split evenly between 9 purchases and 9 sales. The 2024 pattern, a year of sales with zero purchases disclosed, stands out against the more balanced buy-and-sell rhythm seen in most other years.

Sector activity spans a broad range of classifications. The largest bucket is “Unknown,” with 25 of the 123 disclosed transactions. Health Care and Consumer Staples each account for 24, followed by Industrials with 15, Financials with 7, Information Technology with 6, and Communication Services, Energy, and Utilities with 5 each. Consumer Discretionary accounts for 4, Real Estate for 2, and Materials for 1. Examples in the “Unknown” bucket include the iShares MSCI Emerging Markets ex China ETF (EMXC), the Fidelity Mid Cap Index Fund (FSMDX), and the First Eagle SOGEN Global Fund (SGENX), for which the packet does not supply a sector classification.

The March 10, 2025 transactions, disclosed in two reports filed about 16 months apart, illustrate the two attribution streams. The spouse-attributed sales in U.S. Bancorp (USB), Pfizer, Quest Diagnostics, and Target were all in the $15,001 to $50,000 range and disclosed on August 13, 2026. A second batch from the same transaction date, disclosed on April 11, 2025 and self-attributed, shows purchases in Aflac (AFL), Illinois Tool Works (ITW), Gilead Sciences (GILD), Lockheed Martin (LMT), CME Group (CME), PepsiCo (PEP), American Water Works (AWK), Hershey (HSY), and Honeywell (HON), each in the $1,001 to $15,000 range, alongside sales in Quest Diagnostics, Pfizer, Target, U.S. Bancorp, and United Parcel Service (UPS) in the same range. Aflac provides supplemental health and life insurance products in the United States and Japan; CME Group operates contract markets for futures and options; and Lockheed Martin develops and produces aerospace and defense systems across aeronautics, missiles and fire control, rotary and mission systems, and space.

Further back, the 2022 disclosures include purchases in fixed-income and diversified funds such as the iShares 1-3 Year Treasury Bond ETF (SHY), the Schwab U.S. TIPs ETF (SCHP), the Vanguard Growth ETF (VUG), and the Vanguard High Dividend Yield ETF (VYM), alongside purchases of Target, Texas Instruments (TXN), and Quest Diagnostics. That year also included spouse-attributed transactions in industrial names: a sale of Emerson Electric (EMR) and a purchase of United Parcel Service.

Quantellect assigns Miller a Quantellect Score of 25, placing her in the “mixed” tier and ranking her 58th among 76 scored members of Congress as of August 21, 2026. Congressional transaction disclosures governed by the Stop Trading on Congressional Knowledge Act of 2012 and related House Committee on Ethics guidance can include activity attributed to a member, spouse, or dependent child, which is why the attribution attached to each transaction matters.

Disclaimer

This profile is compiled from disclosed transaction data filed under the Stop Trading on Congressional Knowledge Act of 2012 and related House Committee on Ethics financial disclosure guidance. Disclosures may include transactions made by a spouse, dependent child, or other attributed party, not solely the member of Congress. Amounts are reported in ranges as required by law, not exact figures. This content is for informational purposes only and does not constitute investment advice or a recommendation to buy or sell any security.

Trading activity

Trades
123
Companies
78
Disclosed Vol
$3M
Buys
73
59%
Sells
50
41%
Buy / Sell
1.46
ratio

Estimated trading profits

Estimated unrealized profit+$4K
Estimated excess vs S&P 500-$22K (-30.7%)
Win rate67% (6 of 9 buys up)
Average return+6.0%

Based on 9 of 9 disclosed buys with pricing coverage.

Aug 26, 2025 to Aug 25, 2026

Estimated unrealized profit is based on disclosed buy transactions, estimated trade price, and the latest priced-through date. It does not account for later sales, taxes, commissions, slippage, exact execution price, or full portfolio position size. This is descriptive research, not investment advice, and not an allegation of wrongdoing.

Where the Money Sits

share of disclosed trades · top sectors

Periodic Transaction Report filings

CompanyTypeSizeTradedEst. priceChange
TGTTarget Corporation
Sell$15,001 - $50,00010 MAR 2025$107.83+51.60%
DGXQuest Diagnostics Incorporated
Sell$15,001 - $50,00010 MAR 2025$169.23+44.49%
PFEPfizer Inc
Sell$15,001 - $50,00010 MAR 2025$24.43+16.93%
USBU.S. Bancorp
Sell$15,001 - $50,00010 MAR 2025$40.16+55.39%
UPSUnited Parcel Service Inc
Sell$1,001 - $15,00010 MAR 2025$111.03-5.31%
HONHoneywell International Inc
Buy$1,001 - $15,00010 MAR 2025$196.22+9.92%
HSYHershey Co
Buy$1,001 - $15,00010 MAR 2025$179.43+4.32%
AWKAmerican Water Works
Buy$1,001 - $15,00010 MAR 2025$144.61-4.85%
USBU.S. Bancorp
Sell$1,001 - $15,00010 MAR 2025$40.16+55.39%
PEPPepsiCo Inc
Buy$1,001 - $15,00010 MAR 2025$150.23-5.30%
Prev1
Go to

Congressional trading news

The latest news on congressional stock trading, across all members, will appear here as our newsroom publishes it.

Carol D. Miller congressional trading FAQ

Can Carol D. Miller legally trade stocks?

Yes. Members of Congress are permitted to buy and sell stocks, but the 2012 STOCK Act requires them to publicly disclose each transaction, generally within 45 days. Quantellect compiles Carol D. Miller's disclosures so the public can review them.

Where does Quantellect get Carol D. Miller's trading data?

Every trade shown is sourced from official Periodic Transaction Reports filed under the STOCK Act. Amounts are reported as ranges, and estimated prices and post-trade returns are derived from end-of-day market data.

How can I track Carol D. Miller's stock trades?

Quantellect tracks every stock trade Carol D. Miller discloses under the STOCK Act on this page, including the company, the disclosed amount range, and post-trade performance. New filings appear here as they are reported, generally within 45 days of the trade.

How many stock trades has Carol D. Miller disclosed?

Quantellect has tracked 123 disclosed trades by Carol D. Miller across 78 companies.

Which stocks does Carol D. Miller trade most?

Carol D. Miller's most frequently disclosed positions are DGX (4 disclosed trades), PFE (4 disclosed trades), TGT (4 disclosed trades), BTI (3 disclosed trades), CLX (3 disclosed trades), and D (3 disclosed trades), followed by USB, ABT, AFL, and AMGN. The full list of companies and individual filings is shown on this page.

Which sectors does Carol D. Miller invest in?

Healthcare is the heaviest sector in Carol D. Miller's classified disclosures, covering 24 disclosed trades. The full sector breakdown is shown on this page and is derived from the companies behind each disclosed transaction.

What was Carol D. Miller's most recent stock trade?

Carol D. Miller most recently sold Target Corporation (TGT) in March 2025, according to public STOCK Act filings tracked by Quantellect.

What is Carol D. Miller's Quantellect Score?

Carol D. Miller has a Quantellect Score of 25 out of 100 (Mixed). The score ranks members by the estimated unrealized results of their disclosed buys over the last 24 months, weighting estimated total profit, profit versus the S&P 500, and win rate. It is a descriptive research signal, not investment advice or an allegation of unlawful trading.

How much has Carol D. Miller made trading stocks?

Quantellect estimates Carol D. Miller's disclosed buys show an estimated unrealized profit of $4,282 over the trailing 12 months, based on priced disclosed buy transactions through August 25, 2026. This is an estimate and does not account for later sales, taxes, commissions, slippage, exact execution price, or full portfolio position size. It is descriptive research, not investment advice or an allegation of wrongdoing.

Browse all members of Congress who trade stocksSee which stocks Congress tradesCongressional trading overview

Trades reflect disclosures filed under the STOCK Act and are provided for informational purposes only, not investment advice. Amounts are ranges from official filings; estimated prices and post-trade returns are derived from end-of-day market data and may be revised as filings are amended.